Difficulty: Medium
Average Score: 76%
Practice
Drug combinations recommended to be avoided include all, except
Correct answer
D
Rationale
In the context of pediatric cardiovascular disorders, it is crucial for nurses to have a comprehensive understanding of drug combinations to avoid to prevent adverse drug interactions and potential harm to pediatric patients.
Option A) Metronidazole and Warfarin: This combination is known to increase the risk of bleeding due to the potential interaction between metronidazole, an antibiotic, and warfarin, an anticoagulant. Therefore, this combination should be avoided.
Option B) Furosemide and Gentamicin: This combination is known to increase the risk of ototoxicity, particularly in pediatric patients. Both furosemide, a diuretic, and gentamicin, an antibiotic, can individually cause hearing loss, and when used together, the risk is heightened.
Option C) Dihydropyridine calcium channel blockers and beta blockers: This combination is generally safe and is often used together in pediatric patients with cardiovascular disorders to manage conditions such as hypertension and certain heart conditions. Therefore, this combination does not need to be avoided.
Option D) Omega-3 and Antiplatelets: Omega-3 supplements and antiplatelet medications, such as aspirin or clopidogrel, are often used together for their cardiovascular benefits. This combination is generally considered safe and effective in pediatric patients with cardiovascular disorders.
In conclusion, option D is the correct answer as the combination of Omega-3 and Antiplatelets is not recommended to be avoided in pediatric patients with cardiovascular disorders. The other options have known interactions or risks that make them combinations to be cautious about or avoid in pediatric patients. Understanding these drug combinations is essential for safe and effective pediatric nursing care in the management of cardiovascular disorders.
Option A) Metronidazole and Warfarin: This combination is known to increase the risk of bleeding due to the potential interaction between metronidazole, an antibiotic, and warfarin, an anticoagulant. Therefore, this combination should be avoided.
Option B) Furosemide and Gentamicin: This combination is known to increase the risk of ototoxicity, particularly in pediatric patients. Both furosemide, a diuretic, and gentamicin, an antibiotic, can individually cause hearing loss, and when used together, the risk is heightened.
Option C) Dihydropyridine calcium channel blockers and beta blockers: This combination is generally safe and is often used together in pediatric patients with cardiovascular disorders to manage conditions such as hypertension and certain heart conditions. Therefore, this combination does not need to be avoided.
Option D) Omega-3 and Antiplatelets: Omega-3 supplements and antiplatelet medications, such as aspirin or clopidogrel, are often used together for their cardiovascular benefits. This combination is generally considered safe and effective in pediatric patients with cardiovascular disorders.
In conclusion, option D is the correct answer as the combination of Omega-3 and Antiplatelets is not recommended to be avoided in pediatric patients with cardiovascular disorders. The other options have known interactions or risks that make them combinations to be cautious about or avoid in pediatric patients. Understanding these drug combinations is essential for safe and effective pediatric nursing care in the management of cardiovascular disorders.